Lisa Miller | Director-Investor Relations |
Rick Hawkins | Chief Executive Officer, President and Chairman |
John McKew | Chief Operating Officer and Chief Scientific Officer |
Gene Kennedy | Chief Medical Officer |
Carl Langren | Chief Financial Officer |
Charles Duncan | Cantor Fitzgerald |
Ed White | H.C. Wainwright |
Lina Kaminski | JonesTrading |
Yasmeen Rahimi | Piper Sandler |
Elemer Piros | Roth Capital Partners |
Good afternoon, ladies and gentlemen, and welcome to the Lumos Pharma's Year-End 2020 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time.
As a reminder, this conference call is being recorded. I will now turn the call over to Lisa Miller, Director of Investor Relations.